Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Ulusakarya · SciRah

Researcher profile · Semantic Scholar

A. Ulusakarya

Share profile

A. Ulusakarya — researcher profile on SciRah

h-index: 16
Works: 57
Citations: 1,000

Most-cited papers

The circadian timing system in clinical oncology
P. Innominato, Véronique P Roche, O. Palesh, A. Ulusakarya +2 more
2014Annals medicus206 citations Open access
Semantic Scholar
Sleep disruption in breast cancer patients and survivors.
O. Palesh, Arianna Aldridge-Gerry, A. Ulusakarya, Elisabet Ortiz-Tudela +2 more
2013The Journal of the National Comprehensive Cancer Network110 citations
Semantic Scholar
Subjective sleep and overall survival in chemotherapy-naïve patients with metastatic colorectal cancer.
P. Innominato, D. Spiegel, A. Ulusakarya, S. Giacchetti +3 more
2015Sleep Medicine78 citations
Semantic Scholar
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
A. Ulusakarya, E. Chachaty, J. Vantelon, A. Youssef +5 more
2000The Hematology Journal62 citations
Semantic Scholar
Circadian rest‐activity rhythm as an objective biomarker of patient‐reported outcomes in patients with advanced cancer
P. Innominato, S. Komarzynski, O. Palesh, R. Dallmann +10 more
2018Cancer Medicine58 citations Open access
Semantic Scholar
Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases
O. Al Jarroudi, A. Ulusakarya, W. Almohamad, S. Afqir +1 more
2020Cureus42 citations Open access
Semantic Scholar
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial
P. Innominato, A. Karaboué, C. Focan, P. Chollet +7 more
2020International Journal of Cancer36 citations Open access
Semantic Scholar
Relationship Between Subjective and Actigraphy-Measured Sleep in 237 Patients with Metastatic Colorectal Cancer
O. Palesh, K. Haitz, F. Lévi, G. Bjarnason +5 more
2017Quality of Life Research35 citations Open access
Semantic Scholar
Phase 1/2a study of EKB-569, an irreversible inhibitor of epidermal growth factor receptor, in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX-4) in patients with advanced colorectal cancer (CRC).
S. Tejpar, E. Van Cutsem, E. Gamelin, D. Machover +6 more
2004Journal of Clinical Oncology31 citations
Semantic Scholar
Home-Based e-Health Platform for Multidimensional Telemonitoring of Symptoms, Body Weight, Sleep, and Circadian Activity: Relevance for Chronomodulated Administration of Irinotecan, Fluorouracil-Leucovorin, and Oxaliplatin at Home-Results From a Pilot Study.
P. Innominato, S. Komarzynski, A. Karaboué, A. Ulusakarya +6 more
2018JCO Clinical Cancer Informatics29 citations
Semantic Scholar
Acute renal failure related to oxaliplatin-induced intravascular hemolysis
A. Ulusakarya, S. Misra, M. Haydar, H. Habert +4 more
2010Medical Oncology29 citations
Semantic Scholar
Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project
P. Innominato, S. Komarzynski, A. Mohammad-Djafari, A. Arbaud +14 more
2016Journal of Medical Internet Research26 citations Open access
Semantic Scholar
Relevance of a Mobile Internet Platform for Capturing Inter- and Intrasubject Variabilities in Circadian Coordination During Daily Routine: Pilot Study
S. Komarzynski, Qi Huang, P. Innominato, Monique Maurice +8 more
2018Journal of Medical Internet Research24 citations Open access
Semantic Scholar
Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis.
D. Machover, J. Zittoun, R. Saffroy, P. Broët +14 more
2002Cancer Research22 citations
Semantic Scholar
Novel somatic mutations of the VHL gene in an erythropoietin‐producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells
F. H. Rad, A. Ulusakarya, S. Gad, M. Sibony +4 more
2008American journal of hematology/oncology20 citations
Semantic Scholar
The day after: correlates of patient-reported outcomes with actigraphy-assessed sleep in cancer patients at home (inCASA project).
S. Komarzynski, Qi Huang, F. Lévi, O. Palesh +7 more
2019Sleep19 citations Open access
Semantic Scholar
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol
A. Boilève, A. Maillard, M. Wagner, C. Dromain +13 more
2020BMC Cancer16 citations Open access
Semantic Scholar
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy
J. Vantelon, J. Munck, J. Bourhis, J. Pico +5 more
2001Bone Marrow Transplantation16 citations
Semantic Scholar
Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients
P. Innominato, S. Komarzynski, R. Dallmann, N. Wreglesworth +6 more
2021Supportive Care in Cancer15 citations
Semantic Scholar
A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
A. Ulusakarya, A. Karaboué, O. Ciacio, G. Pittau +6 more
2020BMC Cancer15 citations Open access
Semantic Scholar
Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma
A. Ulusakarya, Nahla Teyar, A. Karaboué, M. Haydar +6 more
2019Medicine15 citations Open access
Semantic Scholar
Symptoms in cancer patients and an unusual tumor: Case 1. Regression of hypertrophic pulmonary osteoarthropathy following chemotherapy for lung metastases of a nasopharyngeal carcinoma.
A. Ulusakarya, Y. Gumus, N. Brahimi, B. Delmas-Marsalet +5 more
2005Journal of Clinical Oncology15 citations Open access
Semantic Scholar
Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
A. Ulusakarya, J. Lumbroso, O. Casiraghi, S. Koscielny +7 more
1999Leukemia and Lymphoma14 citations
Semantic Scholar
Extraskeletal osteosarcoma of the mediastinum after treatment of a mediastinal germ-cell tumor.
A. Ulusakarya, P. Terrier, J. Régnard, V. D. De Montpreville +1 more
1999American Journal of Clinical Oncology11 citations
Semantic Scholar
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
L. Legros, A. Pascale, C. Guettier, P. Eftekhari +9 more
2023Cancer Chemotherapy and Pharmacology9 citations Open access
Semantic Scholar
Symptoms associated with circadian rest-activity rhythm disruption in 237 patients with metastatic colorectal cancer.
Pasquale F. Innominato, O. Palesh, G. Bjarnason, A. Ulusakarya +2 more
2015Journal of Clinical Oncology7 citations
Semantic Scholar
Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.
D. Machover, B. Delmas-Marsalet, S. Misra, A. Ulusakarya +9 more
2010Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie7 citations
Semantic Scholar
Thiamine deficiency in a patient receiving chemotherapy for acute myeloblastic leukemia
A. Ulusakarya, J. Vantelon, J. Munck, P. Fenaux +1 more
1999American journal of hematology/oncology5 citations
Semantic Scholar
Very late recurrence of Diethylstilbestrol - related clear cell carcinoma of the cervix: case report
A. Adani-Ife, E. Goldschmidt, P. Innominato, A. Ulusakarya +3 more
2015Gynecologic Oncology Research and Practice4 citations Open access
Semantic Scholar
Maintenance therapy with olaparib or selumetinib plus durvalumab (S+D) according to genetic profile of metastatic pancreatic adenocarcinoma (m-PDAC) controlled with modified FOLFIRINOX (mFFX): A phase II randomized MAZEPPA GERCOR D19-02 PRODIGE-72 study.
P. Hammel, M. Ben Abdelghani, Gaël S. Roth, A. Ulusakarya +16 more
2024Journal of Clinical Oncology3 citations
Semantic Scholar
Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948)
M. Bouchahda, A. Ulusakarya, A. Thirot-Bidault, Amal Attari +5 more
2023BMJ Open3 citations Open access
Semantic Scholar
Detection of circulating tumor cells (CTCs) in central venous blood (CVB) versus peripheral venous blood (PVB) in patients with metastatic cancers.
A. Ulusakarya, F. Ye, J. Wechsler, P. Innominato +4 more
20153 citations
Semantic Scholar
Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT031646
A. Boilève, F. Audemar, E. Dupont-Bierre, S. Le Sourd +11 more
2025Annals of Surgical Oncology2 citations
Semantic Scholar
Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
O. Al Jarroudi, H. Chaabouni, A. Ulusakarya, W. Almohamad +4 more
2021Clinical Case Reports2 citations Open access
Semantic Scholar
Improving FOLFIRINOX safety in pancreatic cancer patients through multidimensional remote monitoring and proactive care using a domomedecine mobile platform.
M. Bouchahda, S. Komarzynski, A. Ulusakarya, Amal Attari +5 more
20202 citations
Semantic Scholar
Patient-reported sleep disruption as an independent prognostic factor for overall survival in metastatic colorectal cancer.
A. Ulusakarya, O. Palesh, G. Bjarnason, C. Deguzman +5 more
20142 citations
Semantic Scholar
Modulation of FU with high-dose folinic acid is effective for treatment of patients with gastric carcinoma.
D. Machover, A. Ulusakarya, E. Goldschmidt
2008Journal of Clinical Oncology2 citations
Semantic Scholar
Images in clinical medicine. Aspergilloma.
A. Ulusakarya
2002New England Journal of Medicine2 citations
Semantic Scholar
Is cure possible for breast cancer metastatic to the liver?
René Adam, D. Badrudin, M. Allard, N. Golse +11 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
Hepatic metastases resection after cetuximab: are we missing something?
A. Ulusakarya, P. Innominato, M. Bouchahda, F. Lévi +1 more
2020The Lancet Oncology1 citations
Semantic Scholar
Patient-tailored FOLFIRINOX in the first-line treatment of patients (pts) with advanced pancreatic cancer (PC).
A. Ulusakarya, Nahla Teyar, A. Karaboué, M. Haydar +5 more
20181 citations
Semantic Scholar
Objective sleep duration (SD) and overall survival (OS) in patients (pts) with metastatic colorectal cancer (MCC).
D. Spiegel, F. Lévi, G. Bjarnason, A. Ulusakarya +2 more
20161 citations
Semantic Scholar
Blepharitis induced by epidermal growth factor receptor-targeting therapy.
A. Ulusakarya, Y. Gumus, B. Delmas-Marsalet, D. Machover
2006American Journal of Clinical Oncology1 citations
Semantic Scholar
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx), and rituximab plus DHAOx (R-DHAOx) for treatment of patients with B-cell non-Hodgkin's lymphoma: Results from two consecutive phase II studies
D. Machover, B. Delmas-Marsalet, Y. Gumus, S. Misra +5 more
20041 citations
Semantic Scholar
Multicentre trial of telemonitored circadian rhythms and electronic patient-reported outcomes (ePROs) for improving tolerability of initial mFOLFIRINOX cycles in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC): MultiDom (NCT04263948).
F. Lévi, Claudia Viaro, A. Ulusakarya, S. Dulong +13 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.
Réne Adam, T. Matsumoto, Caterina Accardo, Yosuke Nakao +16 more
2026Cancer Treatment Reviews0 citations
Semantic Scholar
Assessing circadian rhythms and chemotherapy safety in remote patients with pancreatic ductal adenocarcinoma (PDAC) using a multidimensional digital platform (MultiDom, NCT04263948).
F. Lévi, A. Ulusakarya, S. Dulong, Rachel Bossevot +13 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Superior Mesenteric Artery First Approach: A Safe Technique to Achieve Better Oncological Results after Pancreaticoduodenectomy for Cancer
G. Pittau, N. Beghdadi, D. Pietrasz, P. Romano +7 more
2023HPB0 citations Open access
Semantic Scholar
A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
A. Ulusakarya, A. Karaboué, O. Ciacio, G. Pittau +6 more
2020BMC Cancer0 citations Open access
Semantic Scholar
1038 OBJECTIVE CORRELATES OF SLEEP COMPLAINT IN CANCER PATIENTS ON CHEMOTHERAPY TELE-MONITORED AT HOME: NIGHT-BY-NIGHT ANALYSIS.
S. Komarzynski, F. Lévi, A. Ballesta, M. Bouchahda +4 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Innominato×20
Invite
P. Innominato — researcher profile on SciRah
F. Lévi×15
Invite
F. Lévi — researcher profile on SciRah
M. Bouchahda×13
Invite
M. Bouchahda — researcher profile on SciRah
M. Haydar×13
Invite
M. Haydar — researcher profile on SciRah

×10

Invite

Y. Gumus — researcher profile on SciRah

Invite

O. Palesh — researcher profile on SciRah

A. Karaboué×9

Invite

A. Karaboué — researcher profile on SciRah

Invite

J. Morère — researcher profile on SciRah

Invite

D. Machover — researcher profile on SciRah

S. Komarzynski×8

Invite

S. Komarzynski — researcher profile on SciRah

E. Goldschmidt×8

Invite

E. Goldschmidt — researcher profile on SciRah

Invite

D. Spiegel — researcher profile on SciRah